News

Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2023 on February 7, 2024

Conference Call Scheduled for Wednesday, February 7 at 4:30 p.m. Eastern Time SAN DIEGO, Jan. 31, 2024 /PRNewswire/ — Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel […]

ADVERTISEMENT — Advertise With Biotech Networks
News

Future Origins Launches from Joint Venture to Develop Sustainable Ingredients in Personal Care and Cleaning Products, Announces Completion of Pilot Scale Activities

Unilever, Kao Corporation, L’Oréal and Geno backed entity completed 63,000-liter pilot on time and is advancing toward 2025 decision on first commercial plant SAN DIEGO, Jan. 31, 2024 /PRNewswire/ — Future Origins, a U.S. based […]

News

San Diego-Based Path-Now App Improving Life for Those with Intellectual and Developmental Disabilities

Free App is Earning Rave Reviews from Satisfied IDD Community LOS ANGELES, Jan. 30, 2024 /PRNewswire-PRWeb/ — The San Diego-based Path-Now app is changing the way individuals within the intellectual and developmental disability (IDD) community […]

ADVERTISEMENT — Advertise With Biotech Networks
News

Celebrating Innocycle’s Environmental Milestones: Closed-Loop Recycling Service Makes Significant Impact

SAN DIEGO–(BUSINESS WIRE)–Innovive is proud to announce major environmental milestones achieved by the Closed-Loop Recycling program operated by its sister company, Innocycle. From January 2022 through December 2023, the program has made significant contributions to […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

The Biotech Accelerator Unicorn Program: A Unique Collaboration between CKGSB and the UC San Diego Rady School of Management

SAN DIEGO, Jan. 30, 2024 /PRNewswire/ — Cheung Kong Graduate School of Business (CKGSB) and University of California San Diego (UC San Diego) Rady School of Management are proud to announce the launch of the […]

No Picture
News

AntiCancer Inc. Has Received a New Patent That Revolutionizes Individualized Mouse Models of Human Cancer Patients by Increasing the Patient-tumor Establishment Rate in Mice to Close to 100%

SAN DIEGO–(BUSINESS WIRE)–AntiCancer Inc. announced it has just received US Patent 11,871,731 that describes a method to increase the rate of establishment of patient tumors in mice to close to 100%. Previously the establishment rates […]

News

Halozyme Announces Takeda Received European Commission Approval for HYQVIA® Co-formulated with ENHANZE® as Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

SAN DIEGO, Jan. 29, 2024 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced that Takeda received European Commission (EC) approval for HYQVIA® [Immune Globulin Infusion 10% (Human)] co-formulated with Halozyme’s ENHANZE® drug delivery […]

ADVERTISEMENT — Advertise With Biotech Networks
News

Phanes Therapeutics, Inc. announces granting of registered trademarks for its three proprietary technology platforms by the U.S. Patent and Trademark Office

SAN DIEGO, Jan. 29, 2024 /PRNewswire/ — Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced today that the U.S. Patent and Trademark Office has […]

ADVERTISEMENT — Advertise With Biotech Networks
News

ChromaCode Announces Publication of New Study Demonstrating the Superior Performance of its HDPCR NSCLC Assay Compared to NGS with Low Sample Input

CARLSBAD, Calif., Jan. 26, 2024 /PRNewswire/ — ChromaCode, Inc., a pioneering genomics multiplexing platform company developing accessible and affordable laboratory-based solutions, today announced the publication of a study entitled “NSCLC Digital PCR Panel Returns Low […]

ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
News

Kura’s $150M PIPE; Lilly’s investment in Prism BioLab; Annovis delays PhIII data, citing ‘data cleaning’

Plus, news about IMU Biosciences, ZWI Therapeutics and Sagimet Biosciences: Kura Oncology’s $150M PIPE: The biotech is raising funds from a stock sale to its existing investors, including EcoR1 Capital, an affiliate of Deerfield Management […]

News

Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures

– Expanded indication for ZYNRELEF now covers approximately 13 million procedures annually – SAN DIEGO, Jan. 23, 2024 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that the U.S. Food […]

ADVERTISEMENT — Advertise With Biotech Networks
News

Healcisio AI Reduces Sepsis Mortality By Nearly 20%: NIH Funded Healcisio Collaboration Advances the Development of AI Driven Diagnostic Tools

SAN DIEGO, Jan. 23, 2024 /PRNewswire/ — A recent peer reviewed study published in NPJ Digital Medicine has concluded that Healcisio’s new AI model for sepsis prediction was effective at reducing patient mortality by nearly […]

ADVERTISEMENT — Advertise With Biotech Networks
News

Crown Bioscience's Global Oncology Research Facilities Achieve Prestigious ISO and CAP Accreditations

SAN DIEGO–(BUSINESS WIRE)–Crown Bioscience, a global contract research organization (CRO) and JSR Life Sciences company, proudly announces that its global laboratory facilities have successfully passed a series of annual on-site ISO audits, achieving a flawless […]

News

Trailblazing work with 3D Human Liver Models Yields Accurate MASH (formerly NASH) Phenotype

Viscient has leveraged model to develop novel MASH therapies SAN DIEGO, Jan. 23, 2024 /PRNewswire/ — Viscient Biosciences (“Viscient”) today announced that its scientists, along with collaborators from University of California, San Diego, Sanford-Burnham-Prebys medical […]